Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005311119 | SCV005978094 | uncertain significance | Inborn genetic diseases | 2025-01-08 | criteria provided, single submitter | clinical testing | The c.7394A>C (p.E2465A) alteration is located in exon 54 (coding exon 53) of the CEP290 gene. This alteration results from a A to C substitution at nucleotide position 7394, causing the glutamic acid (E) at amino acid position 2465 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004733715 | SCV005343020 | uncertain significance | CEP290-related disorder | 2024-08-12 | no assertion criteria provided | clinical testing | The CEP290 c.7394A>C variant is predicted to result in the amino acid substitution p.Glu2465Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |